Ackermann Michael
Insider CIK 1791249 · OYST Director · TARS Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-06-16 | 2022-07-01 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-06-16 | 2022-07-01 | 7,000 | — | $0 | 7,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2022-06-15 | 2022-06-17 | 4,257 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2022-06-15 | 2022-06-17 | 4,257 | — | $0 | 1,208,273 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | P Buy | 2022-05-05 | 2022-05-09 | 100,000 | $13.50 | $1.35M | 100,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-12-01 | 2021-12-03 | 2,054 | $24.68 | $50.7K | 1,205,353 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-12-01 | 2021-12-03 | 528 | $26.65 | $14.1K | 1,204,016 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-12-01 | 2021-12-03 | 809 | $25.87 | $20.9K | 1,204,544 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-12-01 | 2021-12-03 | 2,442 | $23.85 | $58.2K | 1,207,407 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-11-01 | 2021-11-03 | 869 | $28.18 | $24.5K | 1,209,849 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-11-01 | 2021-11-03 | 4,964 | $27.76 | $137.8K | 1,210,718 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-10-12 | 2021-10-14 | 4,517 | $26.45 | $119.5K | 1,215,682 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-10-12 | 2021-10-14 | 1,116 | $25.56 | $28.5K | 1,220,199 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-10-08 | 2021-10-12 | 200 | $25.03 | $5.0K | 1,221,315 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-09-01 | 2021-09-03 | 5,833 | $25.24 | $147.2K | 1,221,515 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-08-11 | 2021-08-12 | 621 | $25.15 | $15.6K | 1,227,348 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-08-09 | 2021-08-10 | 700 | $25.00 | $17.5K | 1,227,969 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-08-06 | 2021-08-10 | 3,129 | $25.00 | $78.2K | 1,228,669 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-08-05 | 2021-08-06 | 100 | $25.01 | $2.5K | 1,231,898 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-08-05 | 2021-08-06 | 100 | $25.01 | $2.5K | 1,231,798 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-08-05 | 2021-08-06 | 1,183 | $25.00 | $29.6K | 1,231,998 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2021-06-15 | 2021-06-17 | 4,257 | — | $0 | 4,257 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2021-06-15 | 2021-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2021-06-15 | 2021-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award | 2021-06-15 | 2021-06-17 | 4,257 | — | $0 | 1,233,181 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion deriv | 2020-10-20 | 2020-10-20 | 53,939 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion deriv | 2020-10-20 | 2020-10-20 | 9,246 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion | 2020-10-20 | 2020-10-20 | 53,939 | — | $0 | 1,219,678 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion | 2020-10-20 | 2020-10-20 | 9,246 | — | $0 | 1,228,924 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award | 2020-06-08 | 2020-06-10 | 14,805 | — | $0 | 152,162 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 140,567 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 140,567 | — | $0 | 140,567 | SEC↗ |